Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Smoking Cessation × Bupropion × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tobacco Use Disorder 1 Stomach Neoplasms 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Laryngeal Neoplasms 1 Kidney Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Depressive Disorder, Major 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Tobacco Use Cessation Devices 4 Varenicline 3 Nicotine Replacement Therapy 2 Surveys and Questionnaires 1 Sugars 1 Nicotine Chewing Gum 1 Nicotine 1 Motivational Interviewing 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00322205 2017-01-11

Bio-behavioral Lung Cancer Prevention Program

National Institute on Drug Abuse (NIDA)

Phase 4 Completed

Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡